Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors

National Cancer Institute (NCI) · 2010
ClinicalTrials.gov · Datasets · License: Public Domain · 2010
Open Source ↗
central nervous system neoplasm, pineoblastoma, recurrent medulloblastoma, recurrent primitive neuroectodermal tumor, refractory medulloblastoma, refractory peripheral primitive neuroectodermal tumor, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 834871
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.